Transforming treatment for glaucoma patients and reducing healthcare costs in the UK, Europe and the

UCL-led research conducted by Professor Gus Gazzard has demonstrated the clinical and cost effectiveness of selective laser trabeculoplasty (SLT) for glaucoma leading to changes to clinical guidelines

13 February 2023

International policy case study

Research title: Transforming treatment for glaucoma patients and reducing healthcare costs in the UK, Europe and the US
Faculty: UCL Faculty of Brain Sciences
Activity: Research
Policy type: International public health
Country/Region: Europe, North America
Policy partner: Non-UK National Governments (non-EU); Non-UK National Governments (EU); UK Government (Home Departments)

Synopsis

Research led by UCL has demonstrated the clinical- and cost-effectiveness of selective laser trabeculoplasty (SLT) over daily eyedrops and surgery to reduce internal eye pressure in people with glaucoma. The findings have transformed treatment for glaucoma through changes to clinical guidelines in the UK, Europe and the US, reducing outpatient appointments and costs.

International Policy Engagement

UCL research and expertise informs policymaking across the globe. We provide resources and examples of international policy engagement at UCL to support and inform engagement between UCL researchers and the international policy community.

> find out more